Ligia Peralta, MD
Ligia Peralta, MD, FAAP, is an associate professor of pediatrics and epidemiology, chief of the Division of Adolescent and Young Adult Medicine, and director of the Adolescent HIV Program at the University of Maryland Hospital for Children, University of Maryland School of Medicine. Dr. Peralta has more than 17 years of experience in adolescent health and HIV care. Dr. Peralta developed the "One-Stop Shopping" model of service for adolescents and young adults, which includes anonymous, confidential, and free HIV testing and counseling; advanced gynecological examinations, including colposcopy and cervical dysplasia screening using digital photographs; sexual and substance abuse counseling and treatment; and pharmacy, dental and legal services.
Dr. Peralta's areas of research include primary and secondary HIV prevention, innovative HIV testing technologies, HIV disease progression and spectrum of disease, AIDS fatigue and wasting, sexually transmitted infections, pregnancy, and expanding nontraditional ways of delivering care to special youth populations.
Dr. Peralta is currently the principal investigator of the Adolescent Trials Network for HIV/AIDS Interventions (ATN) Baltimore Unit. In addition, she is the principal investigator of a longitudinal study on biological factors impacting the acquisition of sexually transmitted diseases in adolescent women, funded by the National Institutes of Health, and various grants on secondary prevention of HIV. She is the national representative of the Society of Adolescent Medicine to the American Medical Association. She has spearheaded the National HIV Agenda in her native country, the Dominican Republic. Dr. Peralta serves on the National Pediatric and Family HIV Resource Center Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, and has been the recipient of numerous awards, including the 2000 Latinos of Distinction Award conferred by the U.S. Food and Drug Administration and the White House.
April L. Palmer, MD
April L. Palmer, MD, is an associate professor of pediatric infectious diseases at the University of Mississippi Medical Center in Jackson, Mississippi, where she heads the adolescent HIV clinic. Dr. Palmer graduated with distinction and honors in human biology at the University of Kansas before obtaining her MD degree from the University of Kansas Medical School. She completed her pediatric training at the University of Texas Southwestern Medical School in Dallas, Texas, where she was also chief resident, and then completed her pediatric infectious diseases fellowship at the University of Colorado School of Medicine. Dr. Palmer is certified by the American Board of Pediatrics in pediatrics and pediatric infectious diseases. She is a member of the American Academy of Pediatrics, Pediatric Infectious Disease Society, Southern Society of Pediatric Research, American Society of Microbiology, and the Louisiana/Mississippi Infectious Diseases Society. Her current research interests include antiviral medications, congenital viral infections, and adolescent HIV.
Marvin Belzer, MD, FACP
Marvin Belzer, MD, is an associate professor of clinical pediatrics and medicine at the University of Southern California (USC) Keck School of Medicine. He graduated from medical school at USC in 1986. He completed his internship and residency at the University of California Irvine in primary care internal medicine. He completed his fellowship in adolescent medicine at Children's Hospital Los Angeles in 1991. Since 1991, Dr. Belzer has been the medical director of the Risk Reduction Program, and he is the associate director of research at the Division of Adolescent Medicine. Dr. Belzer has one of the largest adolescent HIV clinics in the western United States. He has developed a clinical research program that is engaged in large multisite clinical trials for youth infected with HIV. Current research network affiliations include the Adolescent HIV/AIDS Trails Network, Pediatric AIDS Clinical Trials Group, and the Centers for Disease Control and Prevention's Project Legacy. Dr. Belzer has been involved in multiple studies evaluating medication adherence. He also is involved in HIV prevention studies for high-risk adolescent populations.